Feasibility of using long noncoding RNAs for predicting malignant transformation of cervical epithelium
- 作者: Levakov S.A.1, Obukhova E.A.2, Sheshukova N.A.1, Bol'shakova O.V.3, Shakhparonov M.I.4, Antipova N.V.4,5
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University Ministry of Health of Russia (Sechenov University)
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies of the Federal Medical Biological Agency
- M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry RAS
- RUDN University
- 期: 编号 9 (2021)
- 页面: 120-126
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249416
- DOI: https://doi.org/10.18565/aig.2021.9.120-126
- ID: 249416
如何引用文章
详细
全文:
作者简介
Sergey Levakov
I.M. Sechenov First Moscow State Medical University Ministry of Health of Russia (Sechenov University)
Email: levakoff@yandex.ru
Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology, NV. Sklifosovsky ICM 119991, Russia, Moscow, Trubetskaya str., 8-2
Elizaveta Obukhova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: liza_obukhova@mail.ru
Teaching Assistant at the Department of Obstetrics and Gynecology, NV. Sklifosovsky ICM 119991, Russia, Moscow, Trubetskaya str., 8-2
Natalia Sheshukova
I.M. Sechenov First Moscow State Medical University Ministry of Health of Russia (Sechenov University)
Email: dr.sheshukova@mail.ru
Dr. Med. Sci., Professor at the Department of Obstetrics and Gynecology, NV. Sklifosovsky ICM 119991, Russia, Moscow, Trubetskaya str., 8-2
Olesya Bol'shakova
Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies of the Federal Medical Biological AgencyPh.D., Associate Professor at the Department of Obstetrics and Gynecology of the Academy of Postgraduate Education 125371, Russia, Moscow, Volokolamsk highway, 91
Mikhail Shakhparonov
M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry RAS
Email: shakhparonov@gmail.com
Dr. Sci. (Chemistry), Head of the Laboratory of Membrane and Bioenergetic Systems, Institute of Bioorganic Chemistry 117997, Russia, Moscow, Miklukho-Maklaya str., 16/10
Nadezhda Antipova
M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry RAS; RUDN University
Email: nadine.antipova@gmail.com
Ph.D. (Bio), Senior Researcher at the Laboratory of Membrane and Bioenergetic Systems, Institute of Bioorganic Chemistry; Associate Professor at the Department of Pharmaceutical and Toxicological Chemistry 117997, Russia, Moscow, Miklukho-Maklaya str., 16/10
参考
- Пак Р.В. Эпидемиологические особенности рака шейки матки в мире. Вестник КазНМУ. 2019; 1: 675-7.
- Шахтахтинская Ф.Ч., Намазова-Баранова Л.С., Таточенко В.К., Новикова Д.А., Ткаченко Н.Е. Вирус папилломы человека. Профилактика ВПЧ-ассоциированных заболеваний. Педиатрическая фармакология. 2015; 12(1): 74-8.
- Arbyn M., Gultekin M., Morice P., Nieminen P. et al. The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 2021; 148: 277-84. https://doi.org/10.1002/ijc.33189.
- Ашрафян Л.А., Киселев В.И., Кузнецов И.Н., Серова О.Ф., Узденова З.Х., Герфанова Е.В. Рак шейки матки: проблемы профилактики и скрининга в Российской Федерации. Доктор.ру. 2019; 11(166): 50-4. https://doi.org/10.31550/1727-2378-2019-166-11-50-54.
- Bedell S.L., Goldstein L.S., Goldstein A.R., Goldstein A.T. Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev. 2020; 8: 28-37. https://doi.org/10.1016/j.sxmr.2019.09.005.
- Рябая О.О., Прокофьева А.А. Взаимодействие аутофагии и эпителиальномезенхимального перехода в развитии опухолевой прогрессии. Успехи молекулярной онкологии. 2020; 7(2): 8-19. https://doi.org/10.17650/2313-805X-2020-7-2-8-19.
- Pan Y., Zhang K., Li C., Chen J. et al. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers. Cellular Physiology and Biochemistry. 2016; 40(1-2): 219-29. https://doi.org/10.1159/000452539.
- Xu X.Y., Zhang J., Qi Y.-H., Kong M., Liu S.-A., Hu J.-J. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway. Eur Rev Med Pharmacol Sci. 2018; 22(8): 2218-25. https://doi.org/10.26355/eurrev_201804_14807.
- Бейлерли О.А., Гареев И.Ф., Павлов В.Н., Shiguang Z., Xin C., Кудряшов B.В. Экзосомальные длинные некодирующие РНК как биомаркеры и терапевтические мишени при раке. Креативная хирургия и онкология. 2019; 9(4): 297-304. https://doi.org/10.24060/2076-3093-2019-9-4-297-304.
- Архангельская П.А., Бахидзе Е.В., Берлев И.В., Самсонов Р.Б., Иванов М.К., Малек А.В. Микро-РНК, ВПЧ-инфекция и цервикальный канцерогенез: молекулярные аспекты и перспективы клинического использования. Сибирский онкологический журнал. 2016; 15(4): 88-97. https://doi.org/10.21294/1814-4861-2016-15-4-88-97.
- Chen W., Yang J., Fang H., Li L., Sun J. Relevance Function of Linc-ROR in the Pathogenesis of Cancer. Front Cell Dev Biol. 2020; 8: 696. https://doi.org/10.3389/fcell.2020.00696.
- Yang L., Bai H.-S., Deng Y., Fan L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015; 19(17): 3187-93.
- Shen F., Zheng H., Zhou L., Li W., Xu X. Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429. J Cell Physiol. 2019; 234(7): 11219-26. https://doi.org/10.1002/jcp.27772.
- Бейлерли О.А., Гареев И.Ф. Роль длинных некодирующих РНК в биологии опухолей. Бюллетень сибирской медицины. 2020; 19(1): 125-33. https://doi.org:10.20538/1682-0363-2020-1-125-133.
- Li C., Lu L., Feng B., Zhang K., Han S., Hou D.-R., Chen L.-B., Chu X., Wang R. The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2. Scientific Reports. 2017; 7(1): 4637. https://doi.org/10.1038/s41598-017-04113-w.
- Zhou Q., Guo J., Huang W., Yu X., Xu C., Long X. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2. Mol Oncol. 2020; 14(9): 2231-50. https://doi.org/10.1002/1878-0261.12700.